Reassuringly, IL-10 serum levels and their expressions in T cells were restored in colitis mice when they underwent late onset tofacitinib treatment although tofacitinib had been shown to completely abolish the expression of this STAT3-dependent cytokine in culture. This evidence concerns the gene STAT3 and colitis.